Suppr超能文献

非小细胞肺癌中肿瘤组织与肿瘤浸润性CD4+和CD8+T细胞之间TNFAIP8表达的差异

Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer.

作者信息

Wang Lingcheng, Song Yinghua, Men Xuelin

机构信息

Department of Respiratory Medicine, Jinan No.4 People's Hospital, 50 Shifan Road, Jinan, Shandong Province, 250031, China.

出版信息

Tumour Biol. 2014 Mar;35(3):2319-25. doi: 10.1007/s13277-013-1307-9. Epub 2013 Oct 19.

Abstract

Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) has been recently documented in various malignancies, but its role in non-small cell lung cancer (NSCLC) remains uncertain. In the current study, we investigated the level of TNFAIP8 in NSCLC tissues, adjacent noncancerous lung tissues, healthy lung tissues, CD4+ T cells, and CD8+ T cells by real-time reverse transcription PCR (RT-PCR) and Western blot analysis. Results revealed that the mRNA level of TNFAIP8 was significantly increased in cancer tissue than in healthy lung tissue from donors (p < 0.001). Interestingly, adjacent noncancerous lung tissues also showed higher mRNA level of TNFAIP8 than healthy lung tissue from donors (p < 0.01). Similarly, protein level of TNFAIP8 was elevated in NSCLC tissues and adjacent noncancerous lung tissues. We further analyzed TNFAIP8 expression in CD4+ T cells and CD8+ T cells. Data demonstrated that both mRNA level and protein level were significantly decreased in tumor-infiltrating CD4+ and CD8+ T cells than in peripheral CD4+ and CD8+ T cells. Moreover, patients with advanced stages presented lower protein expression of TNFAIP8 in tumor-infiltrating CD8+ T cells than patients with primary stages (p < 0.05). These results provide evidence that TNFAIP8 plays critical roles in NSCLC and may be used as a therapeutic target for the disease.

摘要

肿瘤坏死因子α诱导蛋白8(TNFAIP8)最近在多种恶性肿瘤中被报道,但它在非小细胞肺癌(NSCLC)中的作用仍不明确。在本研究中,我们通过实时逆转录PCR(RT-PCR)和蛋白质印迹分析,研究了TNFAIP8在NSCLC组织、癌旁非癌肺组织、健康肺组织、CD4⁺ T细胞和CD8⁺ T细胞中的水平。结果显示,与供体的健康肺组织相比,癌组织中TNFAIP8的mRNA水平显著升高(p < 0.001)。有趣的是,癌旁非癌肺组织中TNFAIP8的mRNA水平也高于供体的健康肺组织(p < 0.01)。同样,NSCLC组织和癌旁非癌肺组织中TNFAIP8的蛋白水平也升高。我们进一步分析了TNFAIP8在CD4⁺ T细胞和CD8⁺ T细胞中的表达。数据表明,肿瘤浸润的CD4⁺和CD8⁺ T细胞中的mRNA水平和蛋白水平均显著低于外周CD4⁺和CD8⁺ T细胞。此外,晚期患者肿瘤浸润CD8⁺ T细胞中TNFAIP8的蛋白表达低于早期患者(p < 0.05)。这些结果提供了证据,表明TNFAIP8在NSCLC中起关键作用,可能用作该疾病的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验